Forecasting realized volatility of BIST indices with har-type models
Is this your thesis?
This record came from a bulk archive import. If it’s yours, link it to your profile.
2023
0 views
0 downloads
Advisor: Prof. Dr. Şükriye Tüysüz
Abstract (EN)
In this thesis, realized volatility of a selection of BIST Indices are forecasted with Heterogeneous Autoregressive Model (HAR) and its variations. For this purpose, ticks between 2001 and 2021 are used to generate 5-minute returns, which formed the basis for calculations of realized volatility and other realized measures. In the study, rolling windows are utilized for forecasting the volatility of one day ahead. These predictions are then compared to the actual realized volatilities. The thesis provides a thorough comparison of HAR-type models, and emphasizes the importance of underlying time series' characteristics in forecasting. Moreover, the findings of this thesis also hint at matters of diversification particular to index volatility forecasting. In overall, HAR Models proved to be a successful estimator for Turkish Stock Exchange time series.
Author
Emre Ahmet Köksal
Institution
How to Cite
Emre Ahmet Köksal (Master Thesis). Forecasting realized volatility of BIST indices with har-type models, 2023, Yeditepe University.
Keywords
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Yeditepe University
- Studies on cyclodextrin complexation of a poorly water soluble anti-hyperlipidemic drug, tablet formulation and characterization(2021)
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative(2022)
- Knowledge distillation with foundation models for image segmentation(2023)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)